Vascular remodelling and fibrotic changes in the joint capsule during periprosthetic knee infections

Listen to Brian and Lisa discuss the paper 'Vascular remodelling and fibrotic changes in the joint capsule during periprosthetic knee infections' published in the February 2026 issue of Bone & Joint Research.

Click here to read the paper.

Be the first to know when the next episode is live! Follow our social media accounts, @BoneJointPortal and @BoneJointRes on X, and @bonejointres on Instagram for updates!

Transcript

[00:00:00] Welcome back to another episode of AI Talks with Bone & Joint, brought to you by the publishers of Bone & Joint Research. Today, we're discussing the paper, 'Vascular remodelling and fibrotic changes in the joint capsule during periprosthetic knee infections', published in February 2026 by R Qiao and colleagues. I am Brian, and I'm here with my co-host, Lisa.

Hello, everyone. Today's episode, all about periprosthetic joint infections, or PJIs, is quite fascinating. PJIs are one of the most serious complications following joint arthroplasty, often leading to high recurrence rates despite appropriate treatment. Therefore, understanding the underlying mechanisms is crucial.

This study suggests that alterations in joint capsule vascularization and fibrotic remodeling play a significant role in the pathophysiology of PJI and its recurrence. The authors examined 69 patients undergoing joint arthroplasty surgery and analyzed various factors such as blood [00:01:00] vessel density, pericyte coverage, and collagen deposition.

Let's discuss the methods they used. The researchers employed several techniques, including haematoxylin and eosin staining, Masson’s trichrome, Sirius red staining, immunofluorescence staining, and real-time quantitative polymerase chain reaction. This provided them with comprehensive insights into the vascular and fibrotic changes in the knee joint capsule.

They found that while the number of blood vessels increased, the mean area, diameter, and perimeter of these vessels were significantly reduced in PJI specimens. Additionally, there was a significant reduction in smooth muscle cell and pericyte coverage, indicating compromised vascular integrity. Reduced vessel size and disrupted vessel architecture can severely impair tissue perfusion and immune surveillance, making it difficult for the body to combat infections and deliver antibiotics effectively.

And we must not overlook the fibrotic changes they observed. The [00:02:00] team identified an increase in collagen deposition and enhanced fibrotic remodeling, which can lead to stiffening of the tissues and further impair their function, contributing to the recurrent nature of PJI. Additionally, they performed gene expression analysis, which revealed upregulation of PDGFB, MIG, MMP-9, and collagen type I alpha one, during both explantation and reimplantation phases.

These molecular changes suggest ongoing inflammation and fibrosis, which further complicate the healing process. Indeed, and they also noted the downregulation of vascular endothelial growth factor A and FGF-2 expression, which are critical for angiogenesis and tissue repair. Their consistent suppression implies long-term impairment in the vascular and regenerative capacity of the joint capsule.

In summary, this study highlights the complex interplay between vascular remodeling, [00:03:00] fibrosis, and recurrent infections in PJIs. By targeting these pathways, orthopaedic researchers may develop novel therapeutic strategies to reduce PJI recurrence and improve surgical outcomes.

Absolutely, Brian. This study not only deepens our understanding of PJI but also opens new pathways for enhancing patient care in orthopaedic surgery.

Well, that’s all for this episode of AI Talks with Bone & Joint. Until next time. Thanks for tuning in everyone, goodbye!